Swedencare
Swedencare - Set for another quarter of expanding margins (ABG Sundal Collier)

2019-06-24 20:25
Momentum in North America and Asia likely to continue…
…driving 18% sales growth and 26% EBIT growth in Q2e
Now EV/EBIT above that of animal health peers ’19e-’20e
Q1’19 development comforting for coming quarters
Swedencare’s Q1’19 results showed good progress. Sales growth of 41% trickled down to 78% EBIT growth, driven by both an expanding gross margin and tighter SG&A/sales. Asian sales increased by >200% y-o-y, and currency-adjusted sales from the US grew by 55% y-o-y (despite logistics issues). As we have highlighted earlier, we expect Asia and North America to be the key growth drivers for Swedencare in ‘19e-‘21e. Hence, we view the Q1 development as comforting for coming quarters, and we expect to see an uptick in sales growth in 2019e.

Q2’19e: 18% sales growth and 2pp EBIT margin expansion
For Q2’19e, we estimate sales growth of 18% y-o-y to SEK 30.2m, driven by continued momentum in North America and Asia. We believe that the sales momentum in powder has continued, and we expect to see >60% y-o-y growth in Dental Bones (despite production constraints). We expect the gross margin to increase by 210bp y-o-y to 74.4%, again driven by more in-house production in Ireland. With similar personnel costs, other external expenses and D&A as in Q1’19, we estimate Q2’19 EBIT of SEK 9.3, up 26% y-o-y, for a margin of 30.9% (28.9%). The Q2’19 report is due on 26 July.

Lifted ’19e estimates, 28-17x EV/EBIT ’19e-’21e
Our 2019 estimate revisions stem from updated Q1’19 numbers, the implementation of IFRS 16 (smaller impact) and somewhat higher/lower expectations for Q2’19e/Q4’19e. Longer-term estimates remain largely unchanged. On updated numbers, shares of Swedencare are changing hands at 28-17x EV/EBIT for ‘19e-‘21e. The valuation implies the share is trading 28-8% above animal health peers for ’19e-‘20e, and 6% below the same peers for ‘21e. We expect Swedencare to deliver higher sales/earnings growth and margins vs. its listed animal health peers (see peer comparison on page 5
...

  • Läs mer på Introduce

  • Läsaren av innehållet kan anta att ABG Sundal Collier har erhållit eller kommer att erhålla betalning för utförandet av finansiella företagstjänster från bolaget. Ersättningen är på förhand avtalad och är inte beroende av innehållet.

info@introduce.se (Introduce.se)
ABG Sundal Collier - Introduce.se

Swedencare - I dag

{point.key}

Marknadsöversikt

Stockholmsbörsen, OMXS30

I dag
-
Senast
-
{point.key}

Världsindex

Index +/- % Senast
DAX - -
Hang Seng - -
Nikkei - -

Valutor

Valuta +/- % Senast
USD/SEK - -
EUR/SEK - -
GBP/SEK - -
EUR/USD - -

Räntor

Ränta +/- % Senast
5-års ränta - -
10-års ränta - -

Råvaror

Råvara +/- % Senast
Guld - -
Silver - -
Koppar - -